Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. 4 Planned sale See Remarks sold 25,000 shares at an average $81.85 ($2,046,351)
  2. 4 Planned sale President, Oncology sold 8,333 shares at an average $80.89 ($674,069)
  3. 4 Planned sale Director sold 10,000 shares at an average $114.81 ($1,148,083)
  4. 4 Planned sale President, Oncology sold 8,333 shares at an average $116.10 ($967,448)
  5. 4 Planned sale See Remarks sold 10,000 shares at an average $116.07 ($1,160,731)
  6. 4 Planned sale See Remarks sold 25,000 shares at an average $116.26 ($2,906,601)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Gift Chief Business Officer gave 17,100 shares (gift)
  10. 4 Planned sale President, Oncology sold 296 shares at $100.82 ($29,843)
  11. 4 Option exercise Chief Business Officer acquired 17,493 shares (option exercise)
  12. 4 Planned sale See Remarks sold 10,000 shares at an average $113.49 ($1,134,947)
  13. 4 Planned sale Director sold 10,000 shares at an average $110.69 ($1,106,940)
  14. 4 Grant or award Chief Development Officer acquired 328 shares (grant or award)
  15. 4 Planned sale See Remarks sold 25,000 shares at an average $114.43 ($2,860,737)
  16. 4 Grant or award Chief Financial Officer acquired 276 shares (grant or award)
  17. 4 Grant or award Chief Business Officer acquired 328 shares (grant or award)
  18. 4 Planned sale President, Oncology sold 58,333 shares at an average $110.76 ($6,460,766)
  19. 4 Grant or award See Remarks acquired 260 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 1 of 60 · 1,195 filings